However, as mentioned earlier, the exact conformation that the receptor is in is not clear (inactive or β-arrestin signaling). Therefore, although these structures can be used for screening ...

China’s National Medical Products Administration (NMPA) has approved the marketing authorisation application of Santen ...

Beta-blockers antagonize beta-1 and beta-2 receptors which are the usual targets of the sympathetic nervous system, including epinephrine and norepinephrine. This results in a decreased heart rate ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...